Announced Mon, 29 Jun · 19:44 IST
Board approves variation in IPO proceeds usage of Rs 1000.16 mn
Results View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹1326.90
prior close
₹1329.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.2+0.4-0.4-1.3+0.6+4.7+1.9+2.8+6.9+6.0———
Up moveDown movePending
AI summary
Senores Pharmaceuticals board approved reallocating about Rs 1000.16 million (around Rs 100 crore) of unutilised IPO proceeds out of the total Rs 5000 million (Rs 500 crore) raised at the time of its IPO. The change in use of these funds is subject to shareholder approval through a postal ballot. The board meeting was held on June 29, 2026, from 4:15 PM to 5:00 PM.
Likely market impact
Investors will get to vote via postal ballot on changing the planned use of IPO money; outcome may affect growth plans funded by these proceeds.